Literature DB >> 31104561

The Importance of Uncertainty and Opt-In v. Opt-Out: Best Practices for Decision Curve Analysis.

Kathleen F Kerr1, Tracey L Marsh2, Holly Janes2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31104561      PMCID: PMC6786944          DOI: 10.1177/0272989X19849436

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


× No keyword cloud information.
  7 in total

1.  Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use.

Authors:  Kathleen F Kerr; Marshall D Brown; Kehao Zhu; Holly Janes
Journal:  J Clin Oncol       Date:  2016-05-31       Impact factor: 44.544

2.  A Systematic Review of the Literature Demonstrates Some Errors in the Use of Decision Curve Analysis but Generally Correct Interpretation of Findings.

Authors:  Paolo Capogrosso; Andrew J Vickers
Journal:  Med Decis Making       Date:  2019-02-28       Impact factor: 2.583

3.  Decision curve analysis: a novel method for evaluating prediction models.

Authors:  Andrew J Vickers; Elena B Elkin
Journal:  Med Decis Making       Date:  2006 Nov-Dec       Impact factor: 2.583

4.  Assessing the Clinical Impact of Risk Models for Opting Out of Treatment.

Authors:  Kathleen F Kerr; Marshall D Brown; Tracey L Marsh; Holly Janes
Journal:  Med Decis Making       Date:  2019-01-16       Impact factor: 2.583

5.  Using relative utility curves to evaluate risk prediction.

Authors:  Stuart G Baker; Nancy R Cook; Andrew Vickers; Barnett S Kramer
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2009-10-01       Impact factor: 2.483

Review 6.  Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators.

Authors:  Ben Van Calster; Laure Wynants; Jan F M Verbeek; Jan Y Verbakel; Evangelia Christodoulou; Andrew J Vickers; Monique J Roobol; Ewout W Steyerberg
Journal:  Eur Urol       Date:  2018-09-19       Impact factor: 20.096

7.  Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.

Authors:  Andrew J Vickers; Angel M Cronin; Elena B Elkin; Mithat Gonen
Journal:  BMC Med Inform Decis Mak       Date:  2008-11-26       Impact factor: 2.796

  7 in total
  4 in total

1.  Statistical inference for net benefit measures in biomarker validation studies.

Authors:  Tracey L Marsh; Holly Janes; Margaret S Pepe
Journal:  Biometrics       Date:  2019-11-28       Impact factor: 2.571

2.  Uncertainty and the Value of Information in Risk Prediction Modeling.

Authors:  Mohsen Sadatsafavi; Tae Yoon Lee; Paul Gustafson
Journal:  Med Decis Making       Date:  2022-02-25       Impact factor: 2.749

Review 3.  Noninvasive biomarkers for lung cancer diagnosis, where do we stand?

Authors:  Michael N Kammer; Pierre P Massion
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 3.005

4.  Recalibration Methods for Improved Clinical Utility of Risk Scores.

Authors:  Anu Mishra; Robyn L McClelland; Lurdes Y T Inoue; Kathleen F Kerr
Journal:  Med Decis Making       Date:  2021-10-04       Impact factor: 2.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.